ZA876394B - Dopamine-beta-hydroxylase inhibitors - Google Patents
Dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- ZA876394B ZA876394B ZA876394A ZA876394A ZA876394B ZA 876394 B ZA876394 B ZA 876394B ZA 876394 A ZA876394 A ZA 876394A ZA 876394 A ZA876394 A ZA 876394A ZA 876394 B ZA876394 B ZA 876394B
- Authority
- ZA
- South Africa
- Prior art keywords
- dopamine
- beta
- hydroxylase inhibitors
- hydroxylase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/901,120 US4761415A (en) | 1986-08-28 | 1986-08-28 | Dopamine-β-hydroxylase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA876394B true ZA876394B (en) | 1988-11-30 |
Family
ID=25413629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA876394A ZA876394B (en) | 1986-08-28 | 1987-08-27 | Dopamine-beta-hydroxylase inhibitors |
Country Status (7)
Country | Link |
---|---|
US (1) | US4761415A (da) |
EP (1) | EP0261804A1 (da) |
JP (1) | JPS6363670A (da) |
AU (1) | AU7760987A (da) |
DK (1) | DK440887A (da) |
PT (1) | PT85596B (da) |
ZA (1) | ZA876394B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4628059A (en) * | 1985-10-31 | 1986-12-09 | Smithklein Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
AU2948189A (en) * | 1987-12-31 | 1989-08-01 | Smithkline Beckman Corporation | 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols |
US7195751B2 (en) | 2003-01-30 | 2007-03-27 | Applera Corporation | Compositions and kits pertaining to analyte determination |
US7355045B2 (en) | 2004-01-05 | 2008-04-08 | Applera Corporation | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
US20050148771A1 (en) | 2004-01-05 | 2005-07-07 | Applera Corporation. | Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof |
WO2013134047A2 (en) | 2012-03-07 | 2013-09-12 | The Mclean Hospital Corporation | Aminoquinoline derivatives and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL131192C (da) * | 1965-06-16 | |||
NL131212C (da) * | 1967-09-11 | |||
US4271308A (en) * | 1968-09-04 | 1981-06-02 | Rohm And Haas Company | 4-alkyl-1,2,4-4H-triazole derivatives |
US4120864A (en) * | 1970-08-26 | 1978-10-17 | Rohm And Haas Company | 1,2,4-4H-triazole derivatives |
US3937713A (en) * | 1974-03-07 | 1976-02-10 | Eli Lilly And Company | Process for the preparation of s-triazolo[3,4-b]benzothiazoles |
US4082762A (en) * | 1975-08-25 | 1978-04-04 | Eli Lilly And Company | 4-(2-halophenyl)-1,2,4-triazole-3-thiol compounds |
US4338453A (en) * | 1980-09-17 | 1982-07-06 | The Upjohn Company | Aminoalkyl-1,2,4-triazoles |
US4532331A (en) * | 1983-04-12 | 1985-07-30 | Smithkline Beckman Corporation | 1-Benzyl-2-aminomethyl imidazole derivatives |
US4628059A (en) * | 1985-10-31 | 1986-12-09 | Smithklein Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
-
1986
- 1986-08-28 US US06/901,120 patent/US4761415A/en not_active Expired - Fee Related
-
1987
- 1987-08-24 DK DK440887A patent/DK440887A/da not_active Application Discontinuation
- 1987-08-25 EP EP87307511A patent/EP0261804A1/en not_active Withdrawn
- 1987-08-25 JP JP62212656A patent/JPS6363670A/ja active Pending
- 1987-08-26 PT PT85596A patent/PT85596B/pt unknown
- 1987-08-27 AU AU77609/87A patent/AU7760987A/en not_active Abandoned
- 1987-08-27 ZA ZA876394A patent/ZA876394B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU7760987A (en) | 1988-03-03 |
PT85596B (en) | 1989-11-30 |
DK440887D0 (da) | 1987-08-24 |
PT85596A (en) | 1987-09-01 |
EP0261804A1 (en) | 1988-03-30 |
DK440887A (da) | 1988-02-29 |
JPS6363670A (ja) | 1988-03-22 |
US4761415A (en) | 1988-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT78388A (en) | Dopamine-beta-hydroxylase inhibitors | |
EP0289506A4 (en) | Lipoxygenase inhibitors | |
ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT83076B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT85081A (en) | Irreversible dopamine-beta-hydroxylase inhibitors | |
PT83628B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA889667B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT84904B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT85596A (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA882100B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT86513A (en) | Dopamine-beta-hydroxylase inhibitors | |
PT83626B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA86949B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA882275B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZW4285A1 (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA842962B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA842963B (en) | Dopamine-beta-hydroxylase inhibitors | |
IE880860L (en) | Dopamine-beta-hydroxylase inhibitors | |
IE882030L (en) | Dopamine-beta-hydroxylase inhibitors | |
IE862056L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS | |
IE860327L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS | |
DE3477926D1 (en) | Dopamine-beta-hydroxylase inhibitors | |
CS494486A1 (en) | Inhibitor koroze hlinikovych slitin |